Delivery Order SPE2DB22D3004-SPE2DB24FQM43
Award Date
5/28/24
Potential Completion Date
6/18/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $14,491.41 delivery order is for the supply of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,997.42 Firm Fixed Price Delivery Order covers the supply of INQOVI 35 MG-100 MG TABLET for an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the drug Inqovi 35 mg-100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of INQOVI 35 MG-100 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The $4,830.47 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024, with a completion date of September 27, 2024. The contract is not set aside for a specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $9,660.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of INQOVI 35 MG-100 MG tablets. The $4,830.47 award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This...
This is a $5,119.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 firm fixed-price contract is for the delivery of INQOVI 35 MG-100 MG TABLET UU 5S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen is the prime contractor, with no major subcontractors mentioned. The award is not associated with a specific set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,841.49, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to $999,999,999.00 through December 31, 2025, serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen will provide a comprehensive range of specialty, brand name, generic, and over-the-counter medications, as well as critical...